Identification and Molecular Characterization of A Gene Encoding A Protective Leishmania amazonensis Trp-Asp (WD) Protein

Kimberly Campbell, Vsevolod Popov, Lynn Soong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Several Leishmania proteins have been identified and characterized in pursuit of understanding pathogenesis and protection in cutaneous leishmaniasis. In the present study, we utilized sera from infected BALB/c mice to screen a Leishmania amazonensis amastigote cDNA expression library and obtained the full-length gene that encodes a novel Trp-Asp (WD) protein designated LAWD (for Leishmania antigenic WD protein). The WD family of proteins mediates protein-protein interactions and coordinates the formation of protein complexes. The single-copy LAWD gene is transcribed as a ∼3.1-kb mRNA in both promastigotes and amastigotes, with homologues being detected in several other Leishmania species. Immunoelectron microscopy revealed a predominant localization of the LAWD protein in the flagellar pocket. Analyses of sera from human patients with cutaneous and mucocutaneous leishmaniasis indicated that these individuals mounted significant humoral responses against LAWD. Given that recombinant LAWD protein elicited the production of high levels of gamma interferon, but no detectable levels of interleukin-10 (IL-10), in CD4 + cells of L. amazonensis-infected mice, we further examined whether LAWD could elicit protective immunity. DNA vaccination with the LAWD and IL-12 genes significantly delayed lesion development, which correlated with a dramatic reduction in parasite burdens. Thus, we have successfully identified a promising vaccine candidate and antigenic vehicle to aid in the dissection of the complicated pathogenic immune response of L. amazonensis.

Original languageEnglish (US)
Pages (from-to)2194-2202
Number of pages9
JournalInfection and Immunity
Volume72
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Leishmania
Genes
Proteins
Cutaneous Leishmaniasis
Mucocutaneous Leishmaniasis
Immunoelectron Microscopy
Interleukin-12
Serum
Gene Library
Interleukin-10
Interferon-gamma
Dissection

ASJC Scopus subject areas

  • Immunology

Cite this

Identification and Molecular Characterization of A Gene Encoding A Protective Leishmania amazonensis Trp-Asp (WD) Protein. / Campbell, Kimberly; Popov, Vsevolod; Soong, Lynn.

In: Infection and Immunity, Vol. 72, No. 4, 04.2004, p. 2194-2202.

Research output: Contribution to journalArticle

@article{805205fca8c24c3ab1eb29bdc7f96519,
title = "Identification and Molecular Characterization of A Gene Encoding A Protective Leishmania amazonensis Trp-Asp (WD) Protein",
abstract = "Several Leishmania proteins have been identified and characterized in pursuit of understanding pathogenesis and protection in cutaneous leishmaniasis. In the present study, we utilized sera from infected BALB/c mice to screen a Leishmania amazonensis amastigote cDNA expression library and obtained the full-length gene that encodes a novel Trp-Asp (WD) protein designated LAWD (for Leishmania antigenic WD protein). The WD family of proteins mediates protein-protein interactions and coordinates the formation of protein complexes. The single-copy LAWD gene is transcribed as a ∼3.1-kb mRNA in both promastigotes and amastigotes, with homologues being detected in several other Leishmania species. Immunoelectron microscopy revealed a predominant localization of the LAWD protein in the flagellar pocket. Analyses of sera from human patients with cutaneous and mucocutaneous leishmaniasis indicated that these individuals mounted significant humoral responses against LAWD. Given that recombinant LAWD protein elicited the production of high levels of gamma interferon, but no detectable levels of interleukin-10 (IL-10), in CD4 + cells of L. amazonensis-infected mice, we further examined whether LAWD could elicit protective immunity. DNA vaccination with the LAWD and IL-12 genes significantly delayed lesion development, which correlated with a dramatic reduction in parasite burdens. Thus, we have successfully identified a promising vaccine candidate and antigenic vehicle to aid in the dissection of the complicated pathogenic immune response of L. amazonensis.",
author = "Kimberly Campbell and Vsevolod Popov and Lynn Soong",
year = "2004",
month = "4",
doi = "10.1128/IAI.72.4.2194-2202.2004",
language = "English (US)",
volume = "72",
pages = "2194--2202",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Identification and Molecular Characterization of A Gene Encoding A Protective Leishmania amazonensis Trp-Asp (WD) Protein

AU - Campbell, Kimberly

AU - Popov, Vsevolod

AU - Soong, Lynn

PY - 2004/4

Y1 - 2004/4

N2 - Several Leishmania proteins have been identified and characterized in pursuit of understanding pathogenesis and protection in cutaneous leishmaniasis. In the present study, we utilized sera from infected BALB/c mice to screen a Leishmania amazonensis amastigote cDNA expression library and obtained the full-length gene that encodes a novel Trp-Asp (WD) protein designated LAWD (for Leishmania antigenic WD protein). The WD family of proteins mediates protein-protein interactions and coordinates the formation of protein complexes. The single-copy LAWD gene is transcribed as a ∼3.1-kb mRNA in both promastigotes and amastigotes, with homologues being detected in several other Leishmania species. Immunoelectron microscopy revealed a predominant localization of the LAWD protein in the flagellar pocket. Analyses of sera from human patients with cutaneous and mucocutaneous leishmaniasis indicated that these individuals mounted significant humoral responses against LAWD. Given that recombinant LAWD protein elicited the production of high levels of gamma interferon, but no detectable levels of interleukin-10 (IL-10), in CD4 + cells of L. amazonensis-infected mice, we further examined whether LAWD could elicit protective immunity. DNA vaccination with the LAWD and IL-12 genes significantly delayed lesion development, which correlated with a dramatic reduction in parasite burdens. Thus, we have successfully identified a promising vaccine candidate and antigenic vehicle to aid in the dissection of the complicated pathogenic immune response of L. amazonensis.

AB - Several Leishmania proteins have been identified and characterized in pursuit of understanding pathogenesis and protection in cutaneous leishmaniasis. In the present study, we utilized sera from infected BALB/c mice to screen a Leishmania amazonensis amastigote cDNA expression library and obtained the full-length gene that encodes a novel Trp-Asp (WD) protein designated LAWD (for Leishmania antigenic WD protein). The WD family of proteins mediates protein-protein interactions and coordinates the formation of protein complexes. The single-copy LAWD gene is transcribed as a ∼3.1-kb mRNA in both promastigotes and amastigotes, with homologues being detected in several other Leishmania species. Immunoelectron microscopy revealed a predominant localization of the LAWD protein in the flagellar pocket. Analyses of sera from human patients with cutaneous and mucocutaneous leishmaniasis indicated that these individuals mounted significant humoral responses against LAWD. Given that recombinant LAWD protein elicited the production of high levels of gamma interferon, but no detectable levels of interleukin-10 (IL-10), in CD4 + cells of L. amazonensis-infected mice, we further examined whether LAWD could elicit protective immunity. DNA vaccination with the LAWD and IL-12 genes significantly delayed lesion development, which correlated with a dramatic reduction in parasite burdens. Thus, we have successfully identified a promising vaccine candidate and antigenic vehicle to aid in the dissection of the complicated pathogenic immune response of L. amazonensis.

UR - http://www.scopus.com/inward/record.url?scp=1842536061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842536061&partnerID=8YFLogxK

U2 - 10.1128/IAI.72.4.2194-2202.2004

DO - 10.1128/IAI.72.4.2194-2202.2004

M3 - Article

C2 - 15039343

AN - SCOPUS:1842536061

VL - 72

SP - 2194

EP - 2202

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 4

ER -